Jason at IIATMS has expanded his writing roster recently, and one of his additions is Larry, a lawyer/executive with significant experience in all matters relating to HGH and PED testing. Last night he wrote an extensive and quite entertaining Q&A regarding HGH testing, use and effects that is must-read material for anyone who tries to talk intelligently about this kind of stuff on the interwebs. There’s masses of scientific information-made-accessible in the post, but since I’m a big apologist and everything, this quote stuck out at me:
It seems that when it comes to anti-doping, perception is more important
than reality. The players perceive that HGH is performance-enhancing.
The fans perceive that HGH is performance-enhancing. The anti-doping
forces believe that they have a foolproof test to catch the athletes
using HGH. IN ALL LIKELIHOOD, NONE OF THESE PERCEPTIONS ARE TRUE. Yet
the perceptions takes on lives of their own. It seems likely that
baseball WILL go forward with some kind of HGH testing. The only
question is when.
Put that together with all of the difficulty Larry points out regarding the creation and implementation of HGH tests and you quickly realize that the discussion about HGH use in baseball is really more about politics than it is about performance enhancement.
Infielder Brett Lawrie successfully avoided arbitration and signed a one-year contract with the White Sox on Friday, per a team announcement. FanRag Sports’ Jon Heyman added that the deal was for $3.5 million, significantly lower than the $4.125 million Lawrie was paid by the White Sox in 2016.
The White Sox acquired Lawrie last December in a swap for minor league arms Zack Erwin and J.B. Wendelken. After splitting time at second and third base for the Athletics in 2015, Lawrie slotted in at second base and DH for the White Sox and batted .248/.310/.413 with 12 home runs in 384 PA. While it’s strange to see a healthy, fairly productive player receive a salary reduction in arbitration, Lawrie missed nearly half of the season with a strain in his left hamstring, though he’s projected to return at full health by the start of the 2017 season.
Left-hander Brian Duensing signed a one-year, $2 million contract with the Cubs on Friday, per a report from FanRag Sports’ Jon Heyman.
The free agent spent the bulk of his 2016 season with the Orioles after receiving a call-up from Triple-A Norfolk in early June. He underwent elbow surgery several weeks later when a freak bullpen injury revealed cartilage chips and inflammation in his pitching elbow, but recovered to finish the season with a 4.05 ERA and 10 strikeouts in 13 1/3 innings for the club. The Orioles utilized him for a final out during the AL Wild Card game, during which Duensing recorded a five-pitch strikeout in the ninth inning of their 5-2 loss to the Blue Jays.
The 33-year-old is currently expected to bulk up the Cubs’ left-handed relief corps, with fellow left-hander Mike Montgomery slated for the rotation in 2017.